Valuation Ribomic Inc.

Stocks

Delayed Japan Exchange 07:30:00 02/10/2026 BST			5-day change	1st Jan Change
76.00 ^JPY	-5.00%		0.00%	-2.56%

08-24	Ribomic Announces Completion of Clinical Trial Site Establishment for the Phase 3 Clinical Trial of Umedaptanib Pegol in Achondroplasia	CI
08-13	Ribomic Inc. Provides Non-Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2027	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	10,159	5,997	6,710	3,318	4,370	4,779
Change	-	-40.96%	11.89%	-50.56%	31.71%	9.37%
Enterprise Value (EV) ¹	4,321	1,296	2,385	-81.19	1,333	1,952
Change	-	-69.99%	83.99%	-103.4%	1,741.55%	46.47%
P/E	-7.88x	-3.5x	-3.54x	-3.24x	-3.89x	-3.82x
PBR	1.69x	1.28x	1.53x	0.99x	1.44x	1.68x
PEG	-	-0.1x	0.3x	0.1x	0.3x	0.45x
Capitalization / Revenue	112x	75x	103x	-	2,185x	1,593x
EV / Revenue	47.5x	16.2x	36.7x	-	666x	651x
EV / EBITDA	-3.56x	-0.75x	-1.34x	0.07x	-1.27x	-1.62x
EV / EBIT	-3.48x	-0.74x	-1.33x	0.07x	-1.27x	-1.62x
EV / FCF	-5.69x	-1.38x	-1.97x	0.13x	-1.89x	-2.57x
FCF Yield	-17.6%	-72.4%	-50.8%	793%	-52.8%	-38.9%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-46.16	-59.92	-53.14	-28.69	-25.19	-23.06
Distribution rate	-	-	-	-	-	-
Net sales ¹	91	80	65	-	2	3
EBITDA ¹	-1,214	-1,734	-1,787	-1,106	-1,049	-1,204
EBIT ¹	-1,240	-1,749	-1,787	-1,116	-1,050	-1,207
Net income ¹	-1,187	-1,684	-1,653	-1,024	-1,018	-1,145
Net Debt ¹	-5,838	-4,701	-4,325	-3,399	-3,037	-2,827
Reference price ²	364.00	210.00	188.00	93.00	98.00	88.00
Nbr of stocks (in thousands)	27,909	28,559	35,693	35,675	44,590	54,309
Announcement Date	30/06/21	29/06/22	28/06/23	26/06/24	20/06/25	19/06/26

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
RIBOMIC INC.	-	-	-	-	27.25M
WUXI APPTEC CO., LTD.	21.73x	7.71x	15.48x	1.37%	74.16B
ARGENX SE	29.82x	8.57x	26.7x	0.04%	57.39B
LONZA GROUP AG	32.98x	5.93x	17.77x	0.98%	47.64B
REVOLUTION MEDICINES, INC.	-21.31x	230.81x	-22.97x	-.--%	44.29B
IQVIA HOLDINGS INC.	33.26x	3.23x	13.97x	-.--%	42.5B
BEONE MEDICINES AG	46.77x	5.41x	29.66x	-.--%	40.71B
CELLTRION, INC.	27.63x	7.93x	20.48x	0.41%	30.97B
WUXI BIOLOGICS (CAYMAN) INC.	32.99x	7.05x	18.3x	-.--%	28.53B
BIONTECH SE	-15.1x	5.68x	-7.14x	-.--%	24.34B
Average	20.98x	31.37x	12.47x	0.31%	39.06B
Weighted average by Cap.	22.27x	32.04x	13.55x	0.42%